SERPINA1 and alpha 1-antitrypsin deficiency: Another recent analysis revealed that 9% of COPD/emphysema and 7% of bronchiectasis patients in a large Central and Eastern European cohort were bearing the Pi*ZZ phenotype, confirming that the detection of AATD in these populations is necessary [28].